FDC inks pact to acquire additional stake in FDC SA

08 Aug 2020 Evaluate

FDC has entered into definitive agreements for the acquisition of additional stake in Fair Deal Corporation pharmaceutical SA (PTY), South Africa (FDC SA) through secondary acquisition of 143,000 equity shares of FDC SA, having Face value of RAND 1 each, and representing 44% of the share capital of FOCSA from Pharma Q Holdings Pty (Pharma Q), one of the joint venture partner and settlement of outstanding loan of ZAR 6.5 million equivalent to approximately Rs 2,92,31,280 availed by FOCSA from Pharma Q.

The said transaction is subject to completion of various closing conditions. Upon completion of the transaction, the company would be holding 93% of the equity share capital of FOCSA, whereby FOC SA would become a subsidiary of the company.

FDC is engaged in manufacture of specialized formulations, and oral rehydration salts (ORS).

FDC Share Price

382.45 -4.45 (-1.15%)
20-Jan-2026 12:37 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1640.80
Dr. Reddys Lab 1184.20
Cipla 1380.55
Zydus Lifesciences 876.15
Lupin 2167.35
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×